Activation of these receptors reduces oxidative stress, lowers inflammatory cytokines, and enhances mitochondrial performance
Endpoints will assess the proportion of patients who develop new esophageal varices after 18 months of Belapectin treatment compared to placebo (primary) and the effect of this treatment on the incidence of long-term clinically significant cirrhosis-related events (key secondary endpoint)
Patients without concomitant anti-fibromyalgia treatment achieved better pain reduction than patients who were on treatment at baseline
Wegovy (semaglutide 2.4 mg) is FDA-approved for chronic weight management in patients with obesity (BMI 30) or overweight (BMI 27) with at least one weight-related comorbidity, and since 2024 for cardiovascular risk reduction in patients with established cardiovascular disease and overweight or obesity
Supplementing reduced L-glutathione or its precursor N-acetylcysteine (NAC) theoretically restores this balance, allowing hepatic detoxification pathways to function without being overwhelmed by lipid peroxidation byproducts
GLP1 at the MetabolicCognitive Interface: Reward, Affect, and Memory
